| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.53 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |